Literature DB >> 8774909

Evidence for three major transcription activation elements in the proximal mouse proalpha2(I) collagen promoter.

T Hasegawa1, X Zhou, L A Garrett, E C Ruteshouser, S N Maity, B de Crombrugghe.   

Abstract

In vivo transient expression and in vitro transcription experiments indicated that a segment between -170 and -40 bp upstream of the start of transcription of the mouse proalpha2(I) collagen gene was essential to activate transcription. DNase I protection experiments identified three strong footprints in this segment. Experiments with deletion mutants encompassing the sequences defined by these three footprints indicated that each of the three elements contributed to the transcriptional activity of the promoter. All three elements are GC-rich, redundant sites for a complex set of DNA binding proteins that includes SP1, other proteins that bind to an SP1 consensus site and proteins that bind to a Krox consensus site. In addition, the segment corresponding to the most proximal footprint also binds the multimeric CCAAT binding protein CBF. Addition of an excess amount of oligo- nucleotides corresponding to either of the two distal footprints significantly inhibited in vitro transcription of the -350 bp proalpha2(I) collagen promoter. Anti-SP1 antibodies that completely inhibited transcription of the early SV40 promoter had little effect on transcription of the wild-type -350 bp promoter, suggesting that SP1 has only a minor role in activity of this promoter. Our results show that the segment between base pairs -170 and -40 of the proalpha2(I) collagen promoter, which contains redundant binding sites for a complex set of nuclear proteins, is essential in the transcriptional activity of this promoter in fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774909      PMCID: PMC146084          DOI: 10.1093/nar/24.16.3253

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  Separate binding sites for nuclear factor 1 and a CCAAT DNA binding factor in the mouse alpha 2(I) collagen promoter.

Authors:  J Oikarinen; A Hatamochi; B de Crombrugghe
Journal:  J Biol Chem       Date:  1987-08-15       Impact factor: 5.157

2.  Transcriptional control of the mouse alpha 2(I) collagen gene: functional deletion analysis of the promoter and evidence for cell-specific expression.

Authors:  A Schmidt; P Rossi; B de Crombrugghe
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

3.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

4.  Differential binding of a CCAAT DNA binding factor to the promoters of the mouse alpha 2(I) and alpha 1(III) collagen genes.

Authors:  A Hatamochi; B Paterson; B de Crombrugghe
Journal:  J Biol Chem       Date:  1986-08-25       Impact factor: 5.157

5.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta.

Authors:  P Rossi; G Karsenty; A B Roberts; N S Roche; M B Sporn; B de Crombrugghe
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

6.  A CCAAT DNA binding factor consisting of two different components that are both required for DNA binding.

Authors:  A Hatamochi; P T Golumbek; E Van Schaftingen; B de Crombrugghe
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

7.  An embryonic pattern of expression of a human fetal globin gene in transgenic mice.

Authors:  K Chada; J Magram; F Costantini
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

8.  Selective activation of transcription by a novel CCAAT binding factor.

Authors:  S N Maity; P T Golumbek; G Karsenty; B de Crombrugghe
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

9.  Erythroid-specific expression of human beta-globin genes in transgenic mice.

Authors:  T M Townes; J B Lingrel; H Y Chen; R L Brinster; R D Palmiter
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

10.  Minimal DNA sequences that control the cell lineage-specific expression of the pro alpha 2(I) collagen promoter in transgenic mice.

Authors:  K Niederreither; R N D'Souza; B de Crombrugghe
Journal:  J Cell Biol       Date:  1992-12       Impact factor: 10.539

View more
  7 in total

1.  Sp3 is a transcriptional activator of the human alpha2(I) collagen gene.

Authors:  H Ihn; M Trojanowska
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

2.  Cell-specific in vivo DNA-protein interactions at the proximal promoters of the pro alpha 1(I) and the pro alpha2(I) collagen genes.

Authors:  S S Chen; E C Ruteshouser; S N Maity; B de Crombrugghe
Journal:  Nucleic Acids Res       Date:  1997-08-15       Impact factor: 16.971

3.  PTRF (polymerase I and transcript-release factor) is tissue-specific and interacts with the BFCOL1 (binding factor of a type-I collagen promoter) zinc-finger transcription factor which binds to the two mouse type-I collagen gene promoters.

Authors:  T Hasegawa; A Takeuchi; O Miyaishi; H Xiao; J Mao; K Isobe
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

4.  Regulation of human methylthioadenosine phosphorylase gene by the CBF (CCAAT binding factor)/NF-Y (nuclear factor-Y).

Authors:  Yuwaraj Kadariya; Kaname Nakatani; Junji Nishioka; Takahiko Fujikawa; Warren D Kruger; Tsutomu Nobori
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

5.  Cloning and characterization of a novel sequence-specific single-stranded-DNA-binding protein.

Authors:  D Bayarsaihan; R J Soto; L N Lukens
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

Review 6.  Transcriptional regulation of T helper 17 cell differentiation.

Authors:  Eun Sook Hwang
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

7.  High doses of TGF-β potently suppress type I collagen via the transcription factor CUX1.

Authors:  Maria Fragiadaki; Tetsurou Ikeda; Abigail Witherden; Roger M Mason; David Abraham; George Bou-Gharios
Journal:  Mol Biol Cell       Date:  2011-04-06       Impact factor: 4.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.